Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameMicroport
Stock Code00853
Company Full NameTo be extracted
Industry醫療保健
Principal Activities主要在中國從事醫療器械之開發、制造及銷售業務。
Listing Date2010-09-24
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國上海市張江高科技園區張東路1601號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.microport.com.cn
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 6.10 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 770,857,000

Stock Connect Inclusion Analysis

HK Market Cap ---
Analysis Result Already included in Stock Connect (both)

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 8.29
First Day OpenHK$ 7.25
First Day Change35.90%
First Day Volume254831000.0
First Day Turnover1953430000.0
Use of Proceeds
1、約50%或714.1百萬港元,用于擴大本集團的產品系列; 2、約25%或357.1百萬港元,用于擴充本集團的生產設施; 3、約20%或285.7百萬港元,用于擴大本集團在中國和世界各地; 4、約5%或71.4百萬港元,用于營運資金及為其他一般企業用途提供資金。

Underwriting Syndicate

Joint Sponsors (2)
Credit Suisse (Hong Kong) Limited CE AAO017 Piper Jaffray Asia Limited CE AEG682
Overall Coordinators (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (2)
Credit Suisse (Hong Kong) Limited CE AAO017 PIPER JAFFRAY ASIA SECURITIES LIMITED CE ABO154
Joint Lead Managers (2)
Credit Suisse (Hong Kong) Limited CE AAO017 PIPER JAFFRAY ASIA SECURITIES LIMITED CE ABO154

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman常兆華—
Company Secretary楊兆琳—
No director data available.

Major Shareholders

Major Shareholders & HoldingsOtsuka Pharmaceutical Co.,Ltd.(20.99%);Maxwell Maxcare Science Foundation Limited(18.00%);Shanghai ZJ Hi-Tech Investment Corporation(12.15%);HHLR Advisors, Ltd.(8.42%);HHLR Fund, L.P.(8.06%)
About this page

This page shows Microport (00853) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect